MENU
+Compare
ENTX
Stock ticker: NASDAQ
AS OF
Dec 18, 04:59 PM (EDT)
Price
$2.17
Change
-$0.05 (-2.25%)
Capitalization
81.77M

ENTX Entera Bio Ltd Forecast, Technical & Fundamental Analysis

a manufacturer of flu medicines

Industry Biotechnology
ENTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
a Summary for ENTX with price predictions
Dec 17, 2024

ENTX's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for ENTX turned positive on November 27, 2024. Looking at past instances where ENTX's MACD turned positive, the stock continued to rise in of 50 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on December 04, 2024. You may want to consider a long position or call options on ENTX as a result. In of 91 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

ENTX moved above its 50-day moving average on December 05, 2024 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for ENTX crossed bullishly above the 50-day moving average on December 10, 2024. This indicates that the trend has shifted higher and could be considered a buy signal. In of 12 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ENTX advanced for three days, in of 208 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for ENTX moved out of overbought territory on December 13, 2024. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 27 similar instances where the indicator moved out of overbought territory. In of the 27 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 42 cases where ENTX's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The 50-day moving average for ENTX moved below the 200-day moving average on November 22, 2024. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ENTX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ENTX broke above its upper Bollinger Band on December 05, 2024. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for ENTX entered a downward trend on December 03, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ENTX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (12.674) is normal, around the industry mean (14.664). P/E Ratio (0.000) is within average values for comparable stocks, (87.689). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.783). ENTX has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.012). P/S Ratio (769.231) is also within normal values, averaging (260.687).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ENTX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
ENTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

ENTX is expected to report earnings to fall 25.00% to -5 cents per share on March 27

Entera Bio Ltd ENTX Stock Earnings Reports
Q4'24
Est.
$-0.06
Q3'24
Missed
by $0.03
Q2'24
Est.
$-0.06
Q1'24
Beat
by $0.07
Q4'23
Beat
by $0.02
The last earnings report on November 08 showed earnings per share of -7 cents, missing the estimate of -5 cents. With 27.00K shares outstanding, the current market capitalization sits at 81.77M.
A.I. Advisor
published General Information

General Information

a manufacturer of flu medicines

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
Minrav Building - Fifth Floor
Phone
+972 25327151
Employees
19
Web
https://www.enterabio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WIMI0.880.07
+8.65%
WiMi Hologram Cloud
HRMY33.630.57
+1.72%
Harmony Biosciences Holdings
NVO108.01-0.04
-0.04%
Novo-Nordisk A/S
DGICA16.18-0.20
-1.22%
Donegal Group
LYFT14.01-0.28
-1.96%
Lyft

ENTX and Stocks

Correlation & Price change

A.I.dvisor tells us that ENTX and JSPR have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ENTX and JSPR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ENTX
1D Price
Change %
ENTX100%
+2.30%
JSPR - ENTX
32%
Poorly correlated
+4.66%
OPORF - ENTX
31%
Poorly correlated
N/A
IMNM - ENTX
26%
Poorly correlated
-3.38%
TNFA - ENTX
25%
Poorly correlated
+12.84%
CVAC - ENTX
24%
Poorly correlated
-4.84%
More